Zhejiang Huakang Pharmaceutical Co Ltd - Asset Resilience Ratio
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has an Asset Resilience Ratio of 0.40% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. For the complete balance sheet picture, see 605077 total assets.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Zhejiang Huakang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Huakang Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Huakang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. See Zhejiang Huakang Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥30.00 Million | 0.4% |
| Total Liquid Assets | CN¥30.00 Million | 0.40% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Huakang Pharmaceutical Co Ltd maintains only 0.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Huakang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Huakang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
BASF SE
XETRA:BAS |
Chemicals | 0.11% |
|
Jiangsu Boqian New Materials Stock Co Ltd
SHG:605376 |
Chemicals | 0.00% |
|
Epoxy Base Electronic Material Corp Ltd
SHG:603002 |
Chemicals | 1.49% |
|
Methanex Corporation
TO:MX |
Chemicals | 5.85% |
|
Tangshan Sunfar Silicon Ind
SHG:603938 |
Chemicals | 12.61% |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SHE:002145 |
Chemicals | 0.26% |
|
Hubei Zhenhua Chemical Co Ltd
SHG:603067 |
Chemicals | 0.03% |
|
Guangzhou Lingwe Technology Co. Ltd. A
SHE:301373 |
Chemicals | 4.74% |
Annual Asset Resilience Ratio for Zhejiang Huakang Pharmaceutical Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Huakang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | CN¥28.00K ≈ $4.10K |
CN¥6.99 Billion ≈ $1.02 Billion |
0.00pp |
| 2023-12-31 | 0.00% | CN¥181.67K ≈ $26.58K |
CN¥6.18 Billion ≈ $903.99 Million |
0.00pp |
| 2022-12-31 | 0.01% | CN¥224.00K ≈ $32.78K |
CN¥3.91 Billion ≈ $571.43 Million |
-2.33pp |
| 2021-12-31 | 2.33% | CN¥70.05 Million ≈ $10.25 Million |
CN¥3.00 Billion ≈ $439.58 Million |
-- |
About Zhejiang Huakang Pharmaceutical Co Ltd
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltito… Read more